why choose us

First received: June 15, 2023

Clinical Trial: Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetic Foot Infection

Study Type: INTERVENTIONAL


Official Title: A Phase 2 CT to Evaluate the Safety and Efficacy of Topical Administration of Bacteriophage Therapy TP-102 in Patients With DFI

Brief Summary: TP-102 is a novel bacteriophage cocktail comprised of 5 (five) lytic bacteriophages against Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii.TP-102 is being developed for topical treatment of patients with wound infections including chronic ulcers; applied every other day (three times weekly (TIW)).

Read more